<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MEDIMMUNE, INC'S QUARTERLY REPORT ON FORM 10-Q FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FILING. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-END> SEP-30-1997 <CASH> 3,515 <SECURITIES> 27,273 <RECEIVABLES> 11,432 <ALLOWANCES> 0 <INVENTORY> 28,793 <CURRENT-ASSETS> 72,645 <PP&E> 60,711 <DEPRECIATION> 0 <TOTAL-ASSETS> 136,080 <CURRENT-LIABILITIES> 22,978 <BONDS> 76,292 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 241 <OTHER-SE> 35,815 <TOTAL-LIABILITY-AND-EQUITY> 136,080 <SALES> 26,931 <TOTAL-REVENUES> 27,208 <CGS> 13,903 <TOTAL-COSTS> 68,275 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 2,607 <INCOME-PRETAX> (40,188) <INCOME-TAX> 0 <INCOME-CONTINUING> (40,188) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (40,188) <EPS-PRIMARY> (1.77) <EPS-DILUTED> (1.77)